← All investors
Abingworth
30 portfolio companies · 3 on the map · $43M raised · 3 cities
Portfolio map
3 Abingworth portfolio companies on the map.
Portfolio companies
- TT
Tizona Therapeutics
South San Francisco
Tizona develops next-generation immunotherapies
Biotechnology Research$43MEst. 2015 
Personalis
Fremont
Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.
Biotechnology ResearchPublicEst. 2011- DP
Dicerna Pharmaceuticals
Lexington
Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease.
Pharmaceutical ManufacturingEst. 2007
More portfolio companies
27 more Abingworth investments we track beyond the map.
Alnylam PharmaceuticalsCambridge · Private Equity
Gilead SciencesFoster City · Post-IPO Equity
Q32 BioCambridge · Post-IPO Equity
Antares TherapeuticsBoston · Series A
Spruce BiosciencesSouth San Francisco · Post-IPO Equity
Soleno TherapeuticsRedwood City · Post-IPO Equity
Myricx BioLondon · Series A
Venatorx PharmaceuticalsMalvern · Series C
IFM TherapeuticsBoston · Venture
CymaBay TherapeuticsHayward · Post-IPO Debt
AttenuaMountain View · Series A
SientraFranklin · Series C
GTxMemphis · Post-IPO Equity
ChiasmaNeedham · Series E
Launch TherapeuticsBoston · Private Equity
ParAllele BioscienceWaltham · Convertible Note
SFJ PharmaceuticalsPleasanton · Series A
AmarinBallsbridge · Post-IPO Equity
- IMIntelligent Medical ImplantsZug · Series B
InpharmaticaLondon · Series B
GammaDelta TherapeuticsLondon · Seed
Quantum DotHayward · Series B
Xenogen CorporationAlameda · Venture
Direct ConversionDanderyd · Series B
Iconix BiosciencesMountain View · Venture
NeoRXSan Francisco · Post-IPO Equity
MD On-LineParsippany · Venture
Portfolio map
3 Abingworth portfolio companies on the map.